Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia

TH Kim, R Vemuganti - Journal of Cerebral Blood Flow & …, 2017 - journals.sagepub.com
Both Parkinson's disease (PD) and stroke are debilitating conditions that result in neuronal
death and loss of neurological functions. These two conditions predominantly affect aging …

CDK5-mediated phosphorylation and autophagy of RKIP regulate neuronal death in Parkinson's disease

Z Wen, Y Shu, C Gao, X Wang, G Qi, P Zhang, M Li… - Neurobiology of …, 2014 - Elsevier
Raf kinase inhibitor protein (RKIP) is a major negative mediator of the extracellular signal-
related kinase (ERK)/mitogen-activated protein kinase (MAPK) pathway. The …

Understanding multifactorial architecture of Parkinson's disease: pathophysiology to management

R Kaur, S Mehan, S Singh - Neurological Sciences, 2019 - Springer
Parkinson's disease (PD) is the second most common multifactorial neurodegenerative
disorder affecting 3% of population during elder age. The loss of substantia nigra, pars …

A critical kinase cascade in neurological disorders: PI3K, Akt and mTOR

ZZ Chong, YC Shang, S Wang, K Maiese - Future neurology, 2012 - Taylor & Francis
Neurodegenerative disorders lead to disability and death in a significant proportion of the
world's population. However, many disorders of the nervous system remain with limited …

Inflammatory response in Parkinson's disease

J Yan, Q Fu, L Cheng, M Zhai… - Molecular …, 2014 - spandidos-publications.com
Parkinson's disease (PD) is one of the most common age‑related neurodegenerative
diseases, which results from a number of environmental and inherited factors. PD is …

Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps

OA Levy, C Malagelada, LA Greene - Apoptosis, 2009 - Springer
Parkinson's disease (PD) is a common neurodegenerative disorder. Neuronal cell death in
PD is still poorly understood, despite a wealth of potential pathogenic mechanisms and …

[HTML][HTML] The p38 MAP kinase family as regulators of proinflammatory cytokine production in degenerative diseases of the CNS

AD Bachstetter, LJ Van Eldik - Aging and disease, 2010 - ncbi.nlm.nih.gov
Inflammation in the central nervous system (CNS) is a common feature of age-related
neurodegenerative diseases. Proinflammatory cytokines, such as IL-1β and TNFα, are …

Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs

D Charvin, R Medori, RA Hauser… - Nature Reviews Drug …, 2018 - nature.com
Existing therapeutic strategies for managing Parkinson disease (PD), which focus on
addressing the loss of dopamine and dopaminergic function linked with degeneration of …

SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease

W Wang, L Shi, Y Xie, C Ma, W Li, X Su, S Huang… - Neuroscience …, 2004 - Elsevier
Increasing evidence suggests that c-Jun N-terminal kinase (JNK) is an important kinase
mediating neuronal apoptosis in Parkinson's disease (PD) model induced by 1-methyl-4 …

Targeting AMPK signaling as a neuroprotective strategy in Parkinson's disease

DW Curry, B Stutz, ZB Andrews… - Journal of Parkinson's …, 2018 - content.iospress.com
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is
characterized by the accumulation of intracellular α-synuclein aggregates and the …